Related Experiment Video
Updated: Apr 15, 2026

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
Published on: August 17, 2022
Severe dilated cardiomyopathy induced by adalimumab and ustekinumab
Francisco Javier Membrillo de Novales1, Alberto Ávila Jiménez, Leticia Merino Meléndez
1Department of Internal Medicine Hospital Central de la Defensa Madrid, Spain javimembrillo@gmail.com Department of Cardiology Hospital Central de la Defensa Madrid, Spain Department of Rheumatology Hospital Universitario de la Princesa Madrid, Spain Department of Internal Medicine Hospital Central de la Defensa Madrid, Spain Department of Cardiology Hospital Central de la Defensa Madrid, Spain Department of Internal Medicine Hospital Central de la Defensa Madrid, Spain.
No abstract available in PubMed .
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Rheumatic Heart Disease I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification

